z-logo
open-access-imgOpen Access
Successful treatment of acute promyelocytic leukemia in a patient under hemodialysis with arsenic trioxide
Author(s) -
Hashimoto Akiko,
Tanaka Yasuhiro,
Ishikawa Takayuki,
Shinzato Isaku
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4417
Subject(s) - arsenic trioxide , acute promyelocytic leukemia , medicine , hemodialysis , kidney disease , adverse effect , arsenic , intensive care medicine , retinoic acid , biochemistry , materials science , chemistry , metallurgy , gene
A man with chronic kidney disease (CKD) under hemodialysis was diagnosed with acute promyelocytic leukemia (APL). He received arsenic trioxide as a single agent and achieved complete molecular remission without severe adverse events. Arsenic trioxide (ATO) can be used safely and effectively for APL with CKD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here